BioEclipse Therapeutics
1 clinical trials · Sponsor
◉ Watch BioEclipse Therapeutics
| Record | Firm | Date |
|---|---|---|
| Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies (NCT04282044) | BioEclipse Therapeutics | 2021-01-08 |
Track BioEclipse Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.